L'ipertensione polmonare nelle malattie reumatiche autoimmuni

Translated title of the contribution: Pulmonary hypertension in autoimmune rheumatic diseases

B. Marasini, Marco Massarotti, R. Cossutta, L. Massironi, A. Mantero

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objective. Pulmonary hypertension is a severe and rapidly progressive disease, particularly frequent in patients with rheumatic diseases. The aims of this study were the following: to determine the prevalence of pulmonary hypertension in Italian patients with autoimmune rheumatic diseases, and to evaluate if the presence of a rheumatic disease in general, or of a specific autoimmune rheumatic disease, is a risk factor for the development of pulmonary hypertension. Patients and Methods. One hundred and thirteen Italian patients with connective tissue diseases (105 females, 8 males), aged 19 to 83 yrs, entered the study. Fifty-one had systemic sclerosis (SSc): 49 were females, 2 males, aged 34 to 83 yrs; 41 had limited cutaneous SSc, 8 diffuse cutaneous SSc, and 2 SSc sine scleroderma. Thirty-three patients had systemic lupus erythematosus (SLE): all but one were females, their age ranged from 19 to 82 yrs. Twenty-five had rheumatoid arthritis (RA): 21 females, 4 males, aged 26 to 45 yrs. Three females and one male, 51-77 yrs, had mixed con-nective tissue disease (MCTD). Systolic pulmonary arterial pressure (SPAP) was assessed by Doppler echocardiography. Results. Twenty three patients had pulmonary hypertension, which was more frequent in MCTD than in SLE (75% vs 6.1%, p=0.0002) or in AR (20%, p=0.0313). Pulmonary hypertension was more frequent in SSc than in SLE (25.5% vs 6.1%, p=0.0028) and in limited than in diffuse SSc(21.6% vs 3.9%). SPAP was significanly related to age (R=0.35, P=0.0275), with patients with pulmonary hypertension older than patients with normal SPAP (66±13 vs 52±16 yrs, p=0.0003). Conclusions. These data show a significant association between pulmonary hypertension and autoimmune rheumatic diseases. Therefore pulmonary hypertension assessment seems mandatory, at least in MCTD and SSc. However, more studies are needed to clarify the relationship between age and pulmonary hypertension and to verify whether the low prevalence of pulmonary hypertension we found in our SLE patients is related or not to their lower age.

Original languageItalian
Pages (from-to)114-118
Number of pages5
JournalReumatismo
Volume57
Issue number2
Publication statusPublished - 2005

Fingerprint

Rheumatic Diseases
Pulmonary Hypertension
Autoimmune Diseases
Systemic Scleroderma
Systemic Lupus Erythematosus
Diffuse Scleroderma
Arterial Pressure
Lung
Connective Tissue Diseases
Doppler Echocardiography
Rheumatoid Arthritis
Skin

ASJC Scopus subject areas

  • Rheumatology

Cite this

Marasini, B., Massarotti, M., Cossutta, R., Massironi, L., & Mantero, A. (2005). L'ipertensione polmonare nelle malattie reumatiche autoimmuni. Reumatismo, 57(2), 114-118.

L'ipertensione polmonare nelle malattie reumatiche autoimmuni. / Marasini, B.; Massarotti, Marco; Cossutta, R.; Massironi, L.; Mantero, A.

In: Reumatismo, Vol. 57, No. 2, 2005, p. 114-118.

Research output: Contribution to journalArticle

Marasini, B, Massarotti, M, Cossutta, R, Massironi, L & Mantero, A 2005, 'L'ipertensione polmonare nelle malattie reumatiche autoimmuni', Reumatismo, vol. 57, no. 2, pp. 114-118.
Marasini B, Massarotti M, Cossutta R, Massironi L, Mantero A. L'ipertensione polmonare nelle malattie reumatiche autoimmuni. Reumatismo. 2005;57(2):114-118.
Marasini, B. ; Massarotti, Marco ; Cossutta, R. ; Massironi, L. ; Mantero, A. / L'ipertensione polmonare nelle malattie reumatiche autoimmuni. In: Reumatismo. 2005 ; Vol. 57, No. 2. pp. 114-118.
@article{b198ce4017c245c2a70d180d73e9950e,
title = "L'ipertensione polmonare nelle malattie reumatiche autoimmuni",
abstract = "Objective. Pulmonary hypertension is a severe and rapidly progressive disease, particularly frequent in patients with rheumatic diseases. The aims of this study were the following: to determine the prevalence of pulmonary hypertension in Italian patients with autoimmune rheumatic diseases, and to evaluate if the presence of a rheumatic disease in general, or of a specific autoimmune rheumatic disease, is a risk factor for the development of pulmonary hypertension. Patients and Methods. One hundred and thirteen Italian patients with connective tissue diseases (105 females, 8 males), aged 19 to 83 yrs, entered the study. Fifty-one had systemic sclerosis (SSc): 49 were females, 2 males, aged 34 to 83 yrs; 41 had limited cutaneous SSc, 8 diffuse cutaneous SSc, and 2 SSc sine scleroderma. Thirty-three patients had systemic lupus erythematosus (SLE): all but one were females, their age ranged from 19 to 82 yrs. Twenty-five had rheumatoid arthritis (RA): 21 females, 4 males, aged 26 to 45 yrs. Three females and one male, 51-77 yrs, had mixed con-nective tissue disease (MCTD). Systolic pulmonary arterial pressure (SPAP) was assessed by Doppler echocardiography. Results. Twenty three patients had pulmonary hypertension, which was more frequent in MCTD than in SLE (75{\%} vs 6.1{\%}, p=0.0002) or in AR (20{\%}, p=0.0313). Pulmonary hypertension was more frequent in SSc than in SLE (25.5{\%} vs 6.1{\%}, p=0.0028) and in limited than in diffuse SSc(21.6{\%} vs 3.9{\%}). SPAP was significanly related to age (R=0.35, P=0.0275), with patients with pulmonary hypertension older than patients with normal SPAP (66±13 vs 52±16 yrs, p=0.0003). Conclusions. These data show a significant association between pulmonary hypertension and autoimmune rheumatic diseases. Therefore pulmonary hypertension assessment seems mandatory, at least in MCTD and SSc. However, more studies are needed to clarify the relationship between age and pulmonary hypertension and to verify whether the low prevalence of pulmonary hypertension we found in our SLE patients is related or not to their lower age.",
keywords = "Autoimmune rheumatic diseases, Mixed connective tissue disease, Pulmonary hypertension, Rheumatoid arthritis, Systemic lupus erythematosus, Systemic sclerosis",
author = "B. Marasini and Marco Massarotti and R. Cossutta and L. Massironi and A. Mantero",
year = "2005",
language = "Italian",
volume = "57",
pages = "114--118",
journal = "Reumatismo",
issn = "0048-7449",
publisher = "PAGEPRESS PUBL",
number = "2",

}

TY - JOUR

T1 - L'ipertensione polmonare nelle malattie reumatiche autoimmuni

AU - Marasini, B.

AU - Massarotti, Marco

AU - Cossutta, R.

AU - Massironi, L.

AU - Mantero, A.

PY - 2005

Y1 - 2005

N2 - Objective. Pulmonary hypertension is a severe and rapidly progressive disease, particularly frequent in patients with rheumatic diseases. The aims of this study were the following: to determine the prevalence of pulmonary hypertension in Italian patients with autoimmune rheumatic diseases, and to evaluate if the presence of a rheumatic disease in general, or of a specific autoimmune rheumatic disease, is a risk factor for the development of pulmonary hypertension. Patients and Methods. One hundred and thirteen Italian patients with connective tissue diseases (105 females, 8 males), aged 19 to 83 yrs, entered the study. Fifty-one had systemic sclerosis (SSc): 49 were females, 2 males, aged 34 to 83 yrs; 41 had limited cutaneous SSc, 8 diffuse cutaneous SSc, and 2 SSc sine scleroderma. Thirty-three patients had systemic lupus erythematosus (SLE): all but one were females, their age ranged from 19 to 82 yrs. Twenty-five had rheumatoid arthritis (RA): 21 females, 4 males, aged 26 to 45 yrs. Three females and one male, 51-77 yrs, had mixed con-nective tissue disease (MCTD). Systolic pulmonary arterial pressure (SPAP) was assessed by Doppler echocardiography. Results. Twenty three patients had pulmonary hypertension, which was more frequent in MCTD than in SLE (75% vs 6.1%, p=0.0002) or in AR (20%, p=0.0313). Pulmonary hypertension was more frequent in SSc than in SLE (25.5% vs 6.1%, p=0.0028) and in limited than in diffuse SSc(21.6% vs 3.9%). SPAP was significanly related to age (R=0.35, P=0.0275), with patients with pulmonary hypertension older than patients with normal SPAP (66±13 vs 52±16 yrs, p=0.0003). Conclusions. These data show a significant association between pulmonary hypertension and autoimmune rheumatic diseases. Therefore pulmonary hypertension assessment seems mandatory, at least in MCTD and SSc. However, more studies are needed to clarify the relationship between age and pulmonary hypertension and to verify whether the low prevalence of pulmonary hypertension we found in our SLE patients is related or not to their lower age.

AB - Objective. Pulmonary hypertension is a severe and rapidly progressive disease, particularly frequent in patients with rheumatic diseases. The aims of this study were the following: to determine the prevalence of pulmonary hypertension in Italian patients with autoimmune rheumatic diseases, and to evaluate if the presence of a rheumatic disease in general, or of a specific autoimmune rheumatic disease, is a risk factor for the development of pulmonary hypertension. Patients and Methods. One hundred and thirteen Italian patients with connective tissue diseases (105 females, 8 males), aged 19 to 83 yrs, entered the study. Fifty-one had systemic sclerosis (SSc): 49 were females, 2 males, aged 34 to 83 yrs; 41 had limited cutaneous SSc, 8 diffuse cutaneous SSc, and 2 SSc sine scleroderma. Thirty-three patients had systemic lupus erythematosus (SLE): all but one were females, their age ranged from 19 to 82 yrs. Twenty-five had rheumatoid arthritis (RA): 21 females, 4 males, aged 26 to 45 yrs. Three females and one male, 51-77 yrs, had mixed con-nective tissue disease (MCTD). Systolic pulmonary arterial pressure (SPAP) was assessed by Doppler echocardiography. Results. Twenty three patients had pulmonary hypertension, which was more frequent in MCTD than in SLE (75% vs 6.1%, p=0.0002) or in AR (20%, p=0.0313). Pulmonary hypertension was more frequent in SSc than in SLE (25.5% vs 6.1%, p=0.0028) and in limited than in diffuse SSc(21.6% vs 3.9%). SPAP was significanly related to age (R=0.35, P=0.0275), with patients with pulmonary hypertension older than patients with normal SPAP (66±13 vs 52±16 yrs, p=0.0003). Conclusions. These data show a significant association between pulmonary hypertension and autoimmune rheumatic diseases. Therefore pulmonary hypertension assessment seems mandatory, at least in MCTD and SSc. However, more studies are needed to clarify the relationship between age and pulmonary hypertension and to verify whether the low prevalence of pulmonary hypertension we found in our SLE patients is related or not to their lower age.

KW - Autoimmune rheumatic diseases

KW - Mixed connective tissue disease

KW - Pulmonary hypertension

KW - Rheumatoid arthritis

KW - Systemic lupus erythematosus

KW - Systemic sclerosis

UR - http://www.scopus.com/inward/record.url?scp=27644538067&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27644538067&partnerID=8YFLogxK

M3 - Articolo

VL - 57

SP - 114

EP - 118

JO - Reumatismo

JF - Reumatismo

SN - 0048-7449

IS - 2

ER -